Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Chiara Trincianti, Maria Angela Tosca & Giorgio Ciprandi. (2023) Updates in the diagnosis and practical management of allergic rhinitis. Expert Review of Clinical Pharmacology 16:7, pages 669-676.
Read now
Read now
Eva Santamaria, Iñaki Izquierdo & Marta Valle. (2021) Rupatadine Oral Solution Titration by Body Weight in Paediatric Patients Suffering from Allergic Rhinitis: A Population Pharmacokinetic Study. Clinical Pharmacology: Advances and Applications 13, pages 115-122.
Read now
Read now
Antonio Nieto, María Nieto & Ángel Mazón. (2021) The clinical evidence of second-generation H1-antihistamines in the treatment of allergic rhinitis and urticaria in children over 2 years with a special focus on rupatadine. Expert Opinion on Pharmacotherapy 22:4, pages 511-519.
Read now
Read now
Articles from other publishers (8)
Hanaa Mohamed Khalaf, Sara Mohamed Naguib Abdel Hafez, Ahlam Mohamed Abdalla, Nermeen N. Welson, Walaa Yehia Abdelzaher & Fatma Alzhraa Fouad Abdelbaky. (2022) Role of Platelet-activating factor and HO-1 in mediating the protective effect of rupatadine against 5-fluorouracil-induced hepatotoxicity in rats. Environmental Science and Pollution Research 29:26, pages 40190-40203.
Crossref
Crossref
Mohamed A Ibrahim, Alyaa Abdelfattah Abdelmonaem, Seham A Abdel-Gaber, Heba M Hafez, Sara Mohamed Naguib Abdel Hafez & Walaa Yehia Abdelzaher. (2022) Rupatadine ameliorated ulcerative colitis in rats via modulation of platelet-activatiweng factor/interleukin-6/vascular endothelial growth factor signalling pathway. Journal of Pharmacy and Pharmacology 74:4, pages 537-546.
Crossref
Crossref
Sakshi Kohli, Richa Tayal & Tarang Goyal. (2022) Antihistamines in children: A dermatological perspective. Indian Journal of Paediatric Dermatology 23:1, pages 8.
Crossref
Crossref
Eli O. Meltzer, Nelson Augusto Rosario, Hugo Van Bever & Luiz Lucio. (2021) Fexofenadine: review of safety, efficacy and unmet needs in children with allergic rhinitis. Allergy, Asthma & Clinical Immunology 17:1.
Crossref
Crossref
Eva Knuplez, Eva Maria Sturm & Gunther Marsche. (2021) Emerging Role of Phospholipase-Derived Cleavage Products in Regulating Eosinophil Activity: Focus on Lysophospholipids, Polyunsaturated Fatty Acids and Eicosanoids. International Journal of Molecular Sciences 22:9, pages 4356.
Crossref
Crossref
G.F. Parisi, S. Leonardi, G. Ciprandi, A. Corsico, A. Licari, M. Miraglia del Giudice, D. Peroni, C. Salpietro & G.L. Marseglia. (2020) Antihistamines in children and adolescents: A practical update. Allergologia et Immunopathologia 48:6, pages 753-762.
Crossref
Crossref
Heba M. Hafez, Elshymaa A. Abdel-Hakeem & Hanaa Hassanein. (2020) Rupatadine, a dual antagonist of histamine and platelet-activating factor (PAF), attenuates experimentally induced diabetic nephropathy in rats. Naunyn-Schmiedeberg's Archives of Pharmacology 393:8, pages 1487-1500.
Crossref
Crossref
Amarilla Mandola, Asako Nozawa & Thomas Eiwegger. (2019) Histamine, histamine receptors, and anti-histamines in the context of allergic responses. LymphoSign Journal 6:2, pages 35-51.
Crossref
Crossref